Results
1 -
8 of
8Bortolini R., Mazzini S., Mondelli R., Ragg E., Ulbricht C., Vioglio S., Penco S..
31P NMR studies on the interaction of morpholinyl anthracyclines and related compounds with d(CGTACG)2. Thermodynamic and kinetic parameters, Applied Magnetic Resonance, 1994 Nemorubicin, Anthracycline Chemistry and Biology II Phase I clinical and pharmacological study of oral methoxymorpholinyl doxorubicin (PNU 152243), Cancer Chemotherapy and Pharmacology Hematotoxicity on human bone marrow- and umbilical cord blood-derived progenitor cells and in vitro therapeutic index of methoxymorpholinyldoxorubicin and its metabolites, Cancer Chemotherapy and Pharmacology Effects of paclitaxel, cyclophosphamide, ifosfamide, tamoxifen and cyclosporine on the metabolism of methoxymorpholinodoxorubicin in human liver microsomes, Cancer Chemotherapy and Pharmacology The antitumor efficacy of cytotoxic drugs is potentiated by treatment with PNU 145156E, a growth-factor-complexing molecule, Cancer Chemotherapy and Pharmacology Ongoing phase I and II studies of novel anthracyclines, Cardiovascular Toxicology Down-regulation of the Nucleotide Excision Repair gene XPG as a new mechanism of drug resistance in human and murine cancer cells, Molecular Cancer